Flagler Investment , is a healthcare property investment, development and asset management group. Flagler’s mission is to partner with the Nation’s leading health care providers to improve clinical outcomes and provide exceptional patient experience. Flagler is particularly known for its disruptive investment approach to medical real estate, creative partnership structures and innovative “Care Habitats”. In 2018 the Healthcare Division of the Chinese Multinational Fosun (www.Fosun.com) acquired a majority stake in Flagler.
Our property investment business has over 25 years of investing in commercial real estate across the Americas and EuropeLearn More
Flagler’s new disease specific “Acute Care Habitats” are designed around new frontiers to foster collaborative innovation between physicians, engineers, researchers, industry leaders and patients, all working together with the singular goal of finding cures and improving outcomes.Learn More
FIHA is a one stop shop cloud-based healthcare market intelligence (HMI) application comprised of multiple data sources such as medical demographics and economics.Learn More
Palm Beach Diabetes & Endocrinology is very much looking forward to our move in to the Core Building in 2018 - Our endocrinology practice has been pioneering the fight against diabetes, thyroid disorders and other endocrine conditions, through patient education, goal setting, and individual involvement in a personalized treatment program for over 30 years. Our team approach to excellent patient care will balance perfectly with the other specialty groups in the building to help the patient achieve better outcomes.
- Palm Beach Diabetes & Endocrinology